Rachel King, CEO, GlycoMimetics (BIO Chair) with Kate Neville (Women in Bio)

At the 2013 BIO International Convention, Rachel King discusses how we can enhance the climate for innovation with communication, strong and helpful FDA, and need to protect financial incentives so we can deliver the innovations.